Improving Deceased-Donor Kidney Transplant Outcomes Via a Single Intragraft Injection of C1 Esterase Inhibitor (IMPROVE TRIAL)
Summary
The registered summary isn't in our current data snapshot. Read it on the ClinicalTrials.gov record ↗. Why? →
Investigators
The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.
- Peter S Heeger, MD
Cedars-Sinai Medical Center
Study Chair - Sindhu Chandran, MBBS, MD
Cedars-Sinai Medical Center
Study Chair - Stanley Jordan, MD
Cedars-Sinai Medical Center
Study Chair
A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.
Sites
4 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.
- Cedars Sinai Medical Center
Los Angeles, California, United States
Recruiting - Northwestern Memorial Hospital
Chicago, Illinois, United States
Recruiting - Kansas University Medical Center
Kansas City, Kansas, United States
Recruiting - Montefiore Medical Center
The Bronx, New York, United States
Recruiting
Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.
Drugs studied
No drug or biological interventions are in our data for this study — it may test a procedure, device or behavioral intervention, or the intervention list isn't in our current snapshot. See the registry record ↗. Why? →
Registration & key dates
Registry attributes as recorded on the ClinicalTrials.gov study record.
- Start
- 22 Sept 2025
- Primary completion
- 30 May 2031
- Completion
- 30 May 2032
- Last update posted
- 27 Feb 2026
- Registered enrollment
- 180
- Registry id
- NCT06919003
Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 12 Jul 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.